Finance

Lists
Why is 300725 up 10.09%?
Dive Deeper
300725:SHE
PharmaBlock Sciences Nanjing Inc
CNÂ¥47.25
+10.09%
(+4.33) 1D
Nov 4, 3:04:10 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300725...
Open
CNÂ¥42.91
High
CNÂ¥47.52
Low
CNÂ¥42.21
Mkt. cap
10.04B
Avg. vol.
22.27M
Volume
31.62M
Dividend
0.51%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Aug 25, 2026
P/E ratio
49.58
52-wk high
CNÂ¥57.55
52-wk low
CNÂ¥30.90
EPS
CNÂ¥0.95
Shares outstanding
233.81M
No. of employees
3K
Open
CNÂ¥42.91
High
CNÂ¥47.52
Low
CNÂ¥42.21
Mkt. cap
10.04B
Avg. vol.
22.27M
Volume
31.62M
Dividend
0.51%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Aug 25, 2026
P/E ratio
49.58
52-wk high
CNÂ¥57.55
52-wk low
CNÂ¥30.90
EPS
CNÂ¥0.95
Shares outstanding
233.81M
No. of employees
3K
News stories
From web sources and news partners
About PharmaBlock Sciences Nanjing Inc
CEO-
Employees2.59K
FoundedDec 26, 2006
Headquarters-
SectorPharmaceutical industry
Industry-
Websitepharmablock.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
555.42M
508.03M
551.43M
574.71M
Cost of goods sold
416.74M
344.74M
391.71M
359.56M
Cost of revenue
416.74M
344.74M
391.71M
359.56M
Research and development expenses
29.67M
29.81M
30.87M
34.95M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
64.04M
65.83M
75.78M
79.71M
Operating expense
128.61M
96.71M
109.23M
116.50M
Total operating expenses
545.35M
441.46M
500.94M
476.06M
Operating income
10.07M
66.58M
50.48M
98.65M
Other non operating income
623.93K
-12.44M
11.16M
-38.57M
EBT including unusual items
79.37M
52.80M
61.00M
57.31M
EBT excluding unusual items
20.50M
61.83M
45.99M
86.69M
Income tax expense
9.03M
3.91M
10.44M
5.54M
Effective tax rate
11.38%
7.41%
17.12%
9.67%
Other operating expenses
9.24M
-1.41M
5.91M
988.79K
Net income
70.34M
48.89M
50.56M
51.77M
Net profit margin
12.67%
9.62%
9.17%
9.01%
Earnings per share
-
-
-
-
Interest and investment income
13.93M
8.31M
7.28M
4.32M
Interest expense
-
-618.48K
-649.04K
-
Net interest expenses
13.93M
7.69M
6.64M
4.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
43.77M
100.27M
86.65M
132.34M
Gain or loss from assets sale
-1.15M
-
-84.72K
84.72K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps